KABASURA KUDINEER HELPS CHECK COVID-19, CLAIMS STUDY

has also shown it is safe to use as prophylactic and supportive care, both for non-infected and infected patients. Being a classical Siddha medicine, it can be used to boost immunity and strengthen the body’s defence mechanism at this time. It is a combination of several herbs like ginger, kalmegh, vasa, guduchi, harithaki etc., which are used in traditional Siddha and Ayurveda medicine in strengthening the respiratory system and to treat fever as well. Several studies have been published on anti-inflammatory, anti pyritic and anti-bacterial actions of the product.”

Earlier this year in June, Patanjali launched an Ayurvedic formulation and said it was a cure for the highly infectious disease. On how Kabasura Kudineer is different from Patanjali’s Coronil, Dr Ravi Reddy said: “Kabasuraa Kudineer is mentioned in Ministry of Ayush’s Siddha

Protocol under the anti-viral preventive category for mild and moderate symptoms of cough, sore throat, difficulty in breathing and high fever.”

Dr Kanakavalli, DG CCRS, Chennai, said that they have distributed Kabasuraa Kudineer as prophylactic care in Tamil Nadu for improving immunity and found it to be effective. The company said it conducted a second clinical study at the popular Bengalurubased Narayana Hrudayalaya hospital to evaluate the effect of AYUSH medicines in the management of Covid-19. The medicines studied included Kabasuraa Kudineer, which was administered as an add-on therapy for 15 patients with mild Covid symptoms. Although the company didn’t state whether or not the drug combo proved effective, it did say that the medicine didn’t have any negative impact.

“The study found that use of AYUSH interventions as an add-on therapy did not negatively impact the clinical outcomes in Covid-19. With not a single adverse event, the trial confirmed the safety and tolerability of AYUSH medicines, including Sri Sri Tattva Kabasuraa Kudineer tablets, Shakti Drops and Turmeric plus tablets for use among patients with mild symptoms,” the company stated.

A third study was conducted at the Bangalore Medical College and Research Institute (BMCRI) among 96 healthcare workers stationed at Covid-19 wards. The objective of this study was to evaluate the immune-modulating properties of herbal medicines, including Tulasi Arka, Shakti Drops and Turmeric plus tablets. However, the company said “data is still coming in, but the initial results have been encouraging”.

In September 2020, the Madras High Court encouraged the Centre to popularise Kabasuraa Kudineer, given its effectiveness in boosting one’s immunity.